BCL11A inhibitors (University of Cambridge)

N/A

Report date: 2025/03/18 18:07:16
NME

Base Information

Drug NameBCL11A inhibitors (University of Cambridge)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionB-cell lymphoma/leukemia 11A degraders
TargetsB-cell lymphoma/leukemia 11A
Therapy Area/IndicationsCarcinoma, Squamous Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Cambridge
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Cambridge
Inactive CompaniesN/A
Active IndicationsCarcinoma, Squamous Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A